跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,037 条关于
“Insmed Corporation”
全部
2,037
临床试验
358
药物
115
机构
481
资讯
1,083
去年
Insmed's Brensocatib Wins FDA Approval as First Treatment for Non-Cystic Fibrosis Bronchiectasis
去年
Insmed's Brensocatib NDA Accepted by FDA with Priority Review; Anticipated Launch in Q3 2025
去年
Insmed's Brensocatib Nears NDA Filing with Strong Financial Backing
5个月前
Insmed Discontinues Brensocatib Development for Hidradenitis Suppurativa After Phase 2b Trial Failure
9个月前
Insmed Discontinues Brensocatib Development in Chronic Rhinosinusitis After Phase 2b Trial Failure
去年
Insmed Reports Strong Q2 2025 Results with ARIKAYCE Growth and Brensocatib Approval Pending
去年
Insmed Opens Cambridge R&D Facility Focused on Synthetic Rescue Platform for Rare Diseases
去年
Insmed's Gene Therapy Receives IND Clearance, Aiming to Transform DMD Treatment
8个月前
Insmed Reports Strong BRINSUPRI Launch with $144.6M First Quarter Revenue, Advances Multiple Phase 3 Programs
5个月前
Insmed Discontinues Brensocatib Development for Hidradenitis Suppurativa After Phase 2b Trial Fails to Meet Endpoints
第 1 页,共 109 页
上一页
下一页